Skip to content

Study · Non-randomized trial · n = 50 · 1984

1 result

[Clinico-immunologic changes in patients with cervical cancer after treatment with thymalin].

Dekster LI, Nikolaeva LIa, Bokhman IaV, Letskiĭ VB, Morozov VG

Voprosy onkologii1 Jan 1984

PMID6608824 (opens in a new tab)PepBankPUB-06608824
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. 1 result from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In patients with cervical carcinoma, thymalin had a beneficial effect on various immunosuppressive states.

    In plain wordsIn patients with cervical cancer, thymalin improved various states of immune suppression.

    Peptide
    Thymalin
    Outcome
    Direction not reportedImmunosuppressive states
    Study

    n = 50

    Outcome group
    Immune response · Immune and inflammation
    Studied dose
    Dose not stated

    Source sentences

    Summary
    Thymalin was found to exert a beneficial effect in various immuno-suppressive states involved in carcinoma of uterine cervix.
    1 context sentence
    Summary · context
    The results of a clinical study of a polypeptide preparation of the thymus-thymalin in 50 patients with cervical carcinoma are discussed.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.